<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biosci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Biosci. Rep</journal-id><journal-id journal-id-type="publisher-id">bsr</journal-id><journal-title-group><journal-title>Bioscience Reports</journal-title></journal-title-group><issn pub-type="ppub">0144-8463</issn><issn pub-type="epub">1573-4935</issn><publisher><publisher-name>Portland Press Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7364480</article-id><article-id pub-id-type="pmid">32578854</article-id><article-id pub-id-type="doi">10.1042/BSR20200407</article-id><article-id pub-id-type="publisher-id">BSR20200407</article-id><article-categories><subj-group subj-group-type="heading"><subject>Biochemical Techniques &#x00026; Resources</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Cycle, Growth &#x00026; Proliferation</subject></subj-group><subj-group subj-group-type="heading"><subject>Metabolism</subject></subj-group><subj-group subj-group-type="toc-heading"><subject>Review Articles</subject></subj-group></article-categories><title-group><article-title>The role of Rho GTPases&#x02019; substrates Rac and Cdc42 in osteoclastogenesis and relevant natural medicinal products study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yuan</given-names></name><xref ref-type="aff" rid="AFF1"/><xref ref-type="aff" rid="AFF2"/></contrib><contrib contrib-type="author"><name><surname>Dou</surname><given-names>Yusheng</given-names></name><xref ref-type="aff" rid="AFF3"/></contrib><contrib contrib-type="author"><name><surname>Yan</surname><given-names>Liang</given-names></name><xref ref-type="aff" rid="AFF1"/></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Xiaobin</given-names></name><xref ref-type="aff" rid="AFF1"/></contrib><contrib contrib-type="author"><name><surname>He</surname><given-names>Baorong</given-names></name><email>baoronghespine@163.com</email><xref ref-type="aff" rid="AFF1"/><xref ref-type="corresp" rid="COR1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-3655-3171</contrib-id><name><surname>Kong</surname><given-names>Lingbo</given-names></name><email>lingbokong@163.com</email><xref ref-type="aff" rid="AFF1"/><xref ref-type="corresp" rid="COR1"/></contrib><contrib contrib-type="author"><name><surname>Smith</surname><given-names>Wanli</given-names></name><xref ref-type="aff" rid="AFF4"/></contrib></contrib-group><aff id="AFF1"><label>1</label>Department of Spine Surgery, Honghui Hospital, School of Medicine, Xi&#x02019;an Jiaotong University, Xi'an, China</aff><aff id="AFF2"><label>2</label>Department of Orthopedics, Yan&#x02019;an University Medical School, Yan&#x02019;an, China</aff><aff id="AFF3"><label>3</label>Department of Shoulder and Elbow Joint, Honghui Hospital, School of Medicine, Xi&#x02019;an Jiaotong University, China</aff><aff id="AFF4"><label>4</label>Department of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore, MD, U.S.A.</aff><author-notes><corresp id="COR1"><bold>Correspondence:</bold> Lingbo Kong (<email>lingbokong@163.com</email>) or Baorong He (<email>baoronghespine@163.com</email>)</corresp></author-notes><pub-date pub-type="collection"><day>31</day><month>7</month><year>2020</year></pub-date><pub-date pub-type="epub" iso-8601-date="2020-07-15"><day>15</day><month>7</month><year>2020</year></pub-date><volume>40</volume><issue>7</issue><elocation-id>BSR20200407</elocation-id><history><date date-type="received"><day>15</day><month>2</month><year>2020</year></date><date date-type="rev-recd"><day>07</day><month>5</month><year>2020</year></date><date date-type="accepted"><day>23</day><month>6</month><year>2020</year></date><date date-type="accepted-manuscript"><day>24</day><month>6</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 The Author(s).</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).</license-p></license></permissions><self-uri xlink:href="bsr-40-bsr20200407.pdf"/><abstract><title>Abstract</title><p>Recently, Rho GTPases substrates include Rac (Rac1 and Rac2) and Cdc42 that have been reported to exert multiple cellular functions in osteoclasts, the most prominent of which includes regulating the dynamic actin cytoskeleton rearrangements. In addition, natural products and their molecular frameworks have a long tradition as valuable starting points for medicinal chemistry and drug discovery. Although currently, there are reports about the natural product, which could play a therapeutic role in bone loss diseases (osteoporosis and osteolysis) through the regulation of Rac1/2 and Cdc42 during osteoclasts cytoskeletal structuring. There have been several excellent studies for exploring the therapeutic potentials of various natural products for their role in inhibiting cancer cells migration and function via regulating the Rac1/2 and Cdc42. Herein in this review, we try to focus on recent advancement studies for extensively understanding the role of Rho GTPases substrates Rac1, Rac2 and Cdc42 in osteoclastogenesis, as well as therapeutic potentials of natural medicinal products for their properties on the regulation of Rac1, and/or Rac2 and Cdc42, which is in order to inspire drug discovery in regulating osteoclastogenesis.</p></abstract><kwd-group><kwd>bone</kwd><kwd>Cdc42</kwd><kwd>natural compounds</kwd><kwd>Rac1</kwd><kwd>Rac</kwd><kwd>Rho GTPase</kwd></kwd-group><counts><page-count count="10"/></counts></article-meta></front><body><sec sec-type="intro" id="sec1"><title>Introduction</title><p>Osteoclastogenesis has been defined as a multistep processes of osteoclast differentiation [<xref rid="B1" ref-type="bibr">1</xref>], including several osteoclastic cellular biological functions; such as: migration, cellular contact, cellular fusion and cellular response extracellular factors [<xref rid="B2" ref-type="bibr">2</xref>]. Documented studies demonstrated that osteoclastogenesis initially mediated by two critical cytokines, the macrophage colony stimulating factor-1 (M-CSF) and the receptor activator of nuclear factor-&#x003ba;B ligand (RANKL) [<xref rid="B3" ref-type="bibr">3</xref>]. M-CSF binds to its receptor (cFms) present in osteoclast precursors, which stimulates their proliferation and inhibits their apoptosis; while, RANKL interacts with its receptor RANK in osteoclast precursor cells, and osteoclastognesis is induced [<xref rid="B4" ref-type="bibr">4</xref>] (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>The schematic of osteoclastogenesis</title><p>The cytokines M-CSF and RANKL (from osteoblasts) bind to its receptors cFms and RANKL present in osteoclast precursors, respectively. Then the M-CSF stimulates osteoclast precursors proliferation and inhibits their apoptosis. Besides that, RANKL interacts with its receptor RANK in osteoclast precursor cells, then osteoclastognesis is induced.</p></caption><graphic xlink:href="bsr-40-bsr20200407-g1"/></fig><p>However, at the late stage of osteoclastogenesis, osteoclastic polarization characterized the final maturation of bone resorptive osteoclasts. Notably, during the bone resorption process, osteoclastic polarization involves rearrangement of the actin cytoskeleton, in which a filamentous (F)-actin ring that comprises dense continuous zones of highly dynamic podosomes are formed and consequently an area of membrane that develops into the ruffled border is isolated [<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B6" ref-type="bibr">6</xref>].</p><sec id="sec1-1"><title>Cytoskeletal rearrangement during osteoclastogenesis</title><p>It is worthy to note that during the cytoskeletal rearrangement in the osteoclastogenesis, podosome is the most prominent cytoskeletal structure for the degradation of mineralized bone matrix and associates with the mobility of osteoclasts [<xref rid="B7" ref-type="bibr">7</xref>]. In fact, podosome is not the exclusive organelle in osteoclast, which also includes endothelial cells, and cells from the monocytic lineage such as: dendritic cells (DCs) and macrophages [<xref rid="B8" ref-type="bibr">8</xref>]. Regardless, the presentation of podosomes in various cells, podosomes patterning plays a crucial and unique role in the support osteoclast final maturation [<xref rid="B8" ref-type="bibr">8</xref>]. As early as individual podosome forms within an osteoclast, they are collectively and sequentially organized into different patterns along the life of the same cell. However, these patterns evolve along with osteoclastogenesis from monocytes/macrophages to osteoclast precursors, further to the bone resorptive matured osteoclast. In the early stage of osteoclastogenesis, podosome pattern from apparently random groups of &#x02018;clusters&#x02019; to circle pattern &#x02018;rings&#x02019; in the middle-term stage [<xref rid="B9" ref-type="bibr">9</xref>]. Eventually, in the late stage of osteoclastogenesis, podosome patterns into much massive circular structures, i.e., either &#x02018;sealing zone like structures&#x02019; (SZL, also known as &#x02018;belts&#x02019;) or &#x02018;sealing zones&#x02019; (SZ) [<xref rid="B10" ref-type="bibr">10</xref>].</p></sec><sec id="sec1-2"><title>Rac isoforms (Rac1 and Rac2) in regulation of cytoskeletal arrangement during osteoclastogenesis</title><p>It has been reported that Rac1 and Rac2 are critical GTPases for osteoclast formation and maturation. In fact, Rac1 and Rac2, are intimately associated with the organization of the different types of cellular cytoskeleton, such as: osteoclasts, DCs and macrophages. Notably, these two isoforms are also involved in the osteoclastic adhesive function formation and subsequent bone resorption [<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B12" ref-type="bibr">12</xref>]. However, the specific role of Rac1 and Rac2 in osteoclastogenesis is still unknown. For example, osteoclasts contain NADPH diaphorase activity [<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B14" ref-type="bibr">14</xref>], and free radicals which both could influence bone resorption, however, Rac1 and Rac2 are also essential components of NADPH oxidase [<xref rid="B15" ref-type="bibr">15&#x02013;18</xref>], the enzyme responsible for generating free radicals. Besides that, a study has also demonstrated that Rac1 and Rac2 could regulate the generation of reactive oxygen species (ROS) [<xref rid="B19" ref-type="bibr">19</xref>] and actin remodeling participating in the osteoclastogenesis regulation. Recent study has found that both Rac1 and Rac2 are required for normal RANKL-induced osteoclast differentiation, but Rac1 deletion results in a more profound reduction in osteoclast formation <italic>in vitro</italic> because of its regulatory role in pre&#x02010;osteoclast M&#x02010;CSF mediated chemotaxis and actin assembly and RANKL&#x02010;mediated ROS generation [<xref rid="B20" ref-type="bibr">20</xref>]. These results speculated that Rac1 and Rac2 might function in osteoclastic organelle actin dynamics regulating, such as: actin filament ends and podosomes. In fact, Rac1 and Rac2 proteins have overlapping roles in podosome assembly and SZL formation by localizing Arp2/3 at podosome sites during osteoclastogenesis [<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B21" ref-type="bibr">21&#x02013;27</xref>]. Osteoclasts generated from the Rac1 and Rac2 double knockout mouse are devoid of podosomes and SZ, which finally showed impaired bone resorption capacities [<xref rid="B24" ref-type="bibr">24</xref>,<xref rid="B28" ref-type="bibr">28&#x02013;32</xref>]. Notably, however, these defects are observed only if Rac1 and Rac2 deletion occurs at the early osteoclast precursor stage, which means the Rac1- and Rac2-deficient osteoclasts lack the capabilities of actin cytoskeletal formation.</p></sec><sec id="sec1-3"><title>The role of Cdc42 in regulation of the podosome of osteoclast</title><p>Cdc42 is another Rho family small GTPase [<xref rid="B33" ref-type="bibr">33</xref>]. As a downstream signaling of RANKL, Cdc42 might interact with the Crib domain of the adaptor Par3 [<xref rid="B34" ref-type="bibr">34</xref>,<xref rid="B35" ref-type="bibr">35</xref>], Par6 and atypical PKC (aPKC) [<xref rid="B36" ref-type="bibr">36&#x02013;38</xref>], which forms a quaternary complex to cascade the upper signaling transduction from RANKL and RANK binding, further stimulating the osteoclastogenesis. However, unlike Rac1 and Rac2 the definition role of Cdc42 in osteoclastogenesis is much clearly associated with its actin regulative effects, i.e. the podosome regulation. Recent studies using mice with increased Cdc42 activation due to knockout of its negative regulator Cdc42GAP have shown increased SZ formation and bone resorption, compared with wildtype cells [<xref rid="B27" ref-type="bibr">27</xref>,<xref rid="B39" ref-type="bibr">39</xref>].</p><p>Cdc42 stands as a central player in the regulation of podosome dynamics as it orchestrates podosome actin polymerization, which from the monomeric globular (G)-actin into filamentous (F)-actin, through its canonical effector, Wiscott&#x02013;Aldrich Syndrome protein (WASp) [<xref rid="B40" ref-type="bibr">40&#x02013;42</xref>]. WASp depletion in macrophages leads to a virtual absence of podosomes and a defective chemotactic response under a gradient of M-CSF. Cdc42 binds directly to WASp, a multidomain adapter protein regulating transmission of signals to the actin cytoskeleton. This binding, together with phosphorylation of WASp on tyrosine, induces a dramatic conformational change [<xref rid="B40" ref-type="bibr">40</xref>,<xref rid="B41" ref-type="bibr">41</xref>,<xref rid="B43" ref-type="bibr">43</xref>]. The hydrophobic core is disrupted, releasing the VCA (Verprolin Homology domain-cofilin homology domain&#x02013;acidic region) domain and enabling its interaction with the Arp2/3 complex, thereby promoting actin nucleation [<xref rid="B44" ref-type="bibr">44&#x02013;46</xref>].</p></sec><sec id="sec1-4"><title>Natural products targeting the regulation of Rac1 and Rac2, and Cdc42</title><p>Natural products and their molecular frameworks have a long tradition as valuable starting points for medicinal chemistry and drug discovery. Recently, there has been a revitalization of interest in the inclusion of these chemotypes in compound collections for screening and achieving selective target modulation. Although currently, there have been no reports on the natural product, which could play a therapeutic role in bone loss diseases (osteoporosis and osteolysis) through the regulation of Rac1/2 and Cdc42 during osteoclasts cytoskeletal structuring. There have been several excellent studies exploring the therapeutic potentials of various natural products in regulating cancer cells migration and function (<xref rid="T1" ref-type="table">Table 1</xref>). Here we collected several natural products with a focus on recent advances in their properties on the regulation of Rac1 and/or Rac2 and Cdc42, and related signaling molecules, in order to inspire drug discovery in regulating osteoclastogenesis (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><title>The schematic of molecular mechanisms of Rho GTPases Rac and Cdc42, and relevant therapeutic natural compounds</title><p>During the osteoclastogenesis, after RANKL and RANK binding, the intracellular Rac1, Rac2 and Cdc42 are via GTP associate with podosomes regulation. However, these regulation effects might inhibited by various compounds (Left panel: inhibitory compounds for Rac1 and Rac2; Right panel: inhibitory compounds for Cdc42).</p></caption><graphic xlink:href="bsr-40-bsr20200407-g2"/></fig><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>The source, structure, cells or animal models and mechanisms of ten natural compounds</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Compound name</th><th align="left" rowspan="1" colspan="1">Source</th><th align="left" rowspan="1" colspan="1">Structure</th><th align="left" rowspan="1" colspan="1">Cell lines used for <italic>in vitro</italic> studies</th><th align="left" rowspan="1" colspan="1">Animal models</th><th align="left" rowspan="1" colspan="1">Dose</th><th align="left" rowspan="1" colspan="1">Mechanisms</th><th align="left" rowspan="1" colspan="1">Studies</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Fisetin</td><td rowspan="1" colspan="1"><italic>polyphenolic molecule of flavonoids</italic></td><td rowspan="1" colspan="1"><inline-graphic xlink:href="bsr-40-bsr20200407-i1.jpg"/></td><td rowspan="1" colspan="1">Neuron</td><td rowspan="1" colspan="1">Wistar rats</td><td rowspan="1" colspan="1">30 mg/kg</td><td rowspan="1" colspan="1">Rac1/Cdc42</td><td rowspan="1" colspan="1">Jacob [<xref rid="B50" ref-type="bibr">50</xref>]</td></tr><tr><td rowspan="1" colspan="1">Deacetyl- mycoepoxydiene</td><td rowspan="1" colspan="1"><italic>Phomopsis sp., of costal mangrove</italic></td><td rowspan="1" colspan="1"><inline-graphic xlink:href="bsr-40-bsr20200407-i2.jpg"/></td><td rowspan="1" colspan="1">Human breast cancer MCF-7 cells</td><td rowspan="1" colspan="1">BABL/c mice</td><td rowspan="1" colspan="1">5, 10, 20 mg/kg</td><td rowspan="1" colspan="1">Rac1</td><td rowspan="1" colspan="1">Zhao [<xref rid="B59" ref-type="bibr">59</xref>]</td></tr><tr><td rowspan="1" colspan="1">Diallyl disulfide</td><td rowspan="1" colspan="1"><italic>garlic</italic></td><td rowspan="1" colspan="1"><inline-graphic xlink:href="bsr-40-bsr20200407-i3.jpg"/></td><td rowspan="1" colspan="1">Human gastric cancer MGC803 cell line</td><td rowspan="1" colspan="1">BALB/c nude mice</td><td rowspan="1" colspan="1">100mg/kg</td><td rowspan="1" colspan="1">Rac1</td><td rowspan="1" colspan="1">Su [<xref rid="B55" ref-type="bibr">55</xref>]</td></tr><tr><td rowspan="1" colspan="1">Plectranthoic acid</td><td rowspan="1" colspan="1"><italic>Ficus microcarpa</italic></td><td rowspan="1" colspan="1"><inline-graphic xlink:href="bsr-40-bsr20200407-i4.jpg"/></td><td rowspan="1" colspan="1">Prostate cancer cell lines (DU145, PC3, NA22, NB26)</td><td rowspan="1" colspan="1">N/A</td><td rowspan="1" colspan="1">N/A</td><td rowspan="1" colspan="1">Rac1</td><td rowspan="1" colspan="1">Akhtar [<xref rid="B61" ref-type="bibr">61</xref>]</td></tr><tr><td rowspan="1" colspan="1">Cudraxanthone S</td><td rowspan="1" colspan="1"><italic>Cudrania cochinchinensis</italic></td><td rowspan="1" colspan="1"><inline-graphic xlink:href="bsr-40-bsr20200407-i5.jpg"/></td><td rowspan="1" colspan="1">N/A</td><td rowspan="1" colspan="1">N/A</td><td rowspan="1" colspan="1">N/A</td><td rowspan="1" colspan="1">Cdc42</td><td rowspan="1" colspan="1">Gopal [<xref rid="B65" ref-type="bibr">65</xref>]</td></tr><tr><td rowspan="1" colspan="1">Panacis Japonici Rhizoma</td><td rowspan="1" colspan="1"><italic>Panax japonicus C. A. Meyer</italic></td><td rowspan="1" colspan="1"><inline-graphic xlink:href="bsr-40-bsr20200407-i6.jpg"/></td><td rowspan="1" colspan="1">A2780 cell line</td><td rowspan="1" colspan="1">N/A</td><td rowspan="1" colspan="1">N/A</td><td rowspan="1" colspan="1">Cdc42</td><td rowspan="1" colspan="1">Chen [<xref rid="B66" ref-type="bibr">66</xref>]</td></tr><tr><td rowspan="1" colspan="1">Triptolide</td><td rowspan="1" colspan="1"><italic>Triterygium wilfordii Hook. f.</italic></td><td rowspan="1" colspan="1"><inline-graphic xlink:href="bsr-40-bsr20200407-i7.jpg"/></td><td rowspan="1" colspan="1">Sprague&#x02013;Dawley (SD) rats</td><td rowspan="1" colspan="1">Sprague&#x02013;Dawley (SD) rats</td><td rowspan="1" colspan="1">100 mg/kg</td><td rowspan="1" colspan="1">Rac1, Cdc42</td><td rowspan="1" colspan="1">Wang [<xref rid="B51" ref-type="bibr">51</xref>]</td></tr><tr><td rowspan="1" colspan="1">TDB (4,5,40-trihydroxy-3, 30- dimethoxybibenzy)</td><td rowspan="1" colspan="1"><italic>Dendrobium ellipsophyllum Tang and Wang</italic></td><td rowspan="1" colspan="1"><inline-graphic xlink:href="bsr-40-bsr20200407-i8.jpg"/></td><td rowspan="1" colspan="1">Human lung cancer H292 cells</td><td rowspan="1" colspan="1">N/A</td><td rowspan="1" colspan="1">N/A</td><td rowspan="1" colspan="1">Rac1/Cdc42</td><td rowspan="1" colspan="1">Chaotham [<xref rid="B74" ref-type="bibr">74</xref>]</td></tr><tr><td rowspan="1" colspan="1">Corosolic acid</td><td rowspan="1" colspan="1"><italic>Actinidia chinensis</italic>,</td><td rowspan="1" colspan="1"><inline-graphic xlink:href="bsr-40-bsr20200407-i9.jpg"/></td><td rowspan="1" colspan="1">Hepatocellular carcinoma cell lines (Huh7, HepG2 and Hep3B)</td><td rowspan="1" colspan="1">NOD/SCID mice</td><td rowspan="1" colspan="1">5 mg/kg</td><td rowspan="1" colspan="1">Cdc42</td><td rowspan="1" colspan="1">Ku [<xref rid="B77" ref-type="bibr">77</xref>]</td></tr><tr><td rowspan="1" colspan="1">Gigantol</td><td rowspan="1" colspan="1"><italic>Thai orchid, Dendrobium draconis</italic></td><td rowspan="1" colspan="1"><inline-graphic xlink:href="bsr-40-bsr20200407-i10.jpg"/></td><td rowspan="1" colspan="1">Human lung carcinoma cells NCI-H460 and NCI-H292</td><td rowspan="1" colspan="1">N/A</td><td rowspan="1" colspan="1">N/A</td><td rowspan="1" colspan="1">Cdc42</td><td rowspan="1" colspan="1">Charoenrungruang [<xref rid="B78" ref-type="bibr">78</xref>]</td></tr></tbody></table></table-wrap></sec><sec id="sec1-5"><title>Rac1 and Rac2 regulative natural products</title><p><italic>Fisetin</italic> (<italic>3,3&#x02032;,4&#x02032;,7-Tetrahydroxyflavone</italic>), is natural product that could be found in vegetables and fruits [<xref rid="B47" ref-type="bibr">47</xref>]. <italic>Fisetin</italic> has been well established and possesses antioxidant [<xref rid="B48" ref-type="bibr">48</xref>] and anti-neurodegenerative progression [<xref rid="B49" ref-type="bibr">49</xref>]. Most recently, Jacob et al. [<xref rid="B50" ref-type="bibr">50</xref>] have reported <italic>Fisetin</italic> showed a significant protective effect on developmental Methyl mercury neurotoxicity in the F<sub>1</sub> generation of MeHg exposed rats. In that, Methyl mercury is a teratogenic and neurodevelopmental toxicant in the environment. Whereas MeHg could affect several biological pathways critical for brain development. Most recently, authors present study validated the effect of <italic>Fisetin</italic> on developmental MeHg exposure induced alterations in mitochondrial apoptotic pathway and Rho GTPase mRNA expressions in hippocampus of F<sub>1</sub> generation rats. Their extensive study showed that Fisetin against gestational MeHg exposure induced changes in expression of ERK/Caspase 3 genes of apoptosis signaling pathway and Rho A/Rac1/Cdc42 genes of Rho GTPase signaling pathway in hippocampus of F<sub>1</sub> generation weaning Wistar rats.</p><p><italic>Deacetyl-mycoepoxydiene</italic> (DA-MED) is a 248 molecular weight compound that has been isolated from the endophytic fungus, <italic>Phomopsis sp.</italic>, of <italic>costal mangrove</italic> plants and has been shown to be a secondary metabolite with a rare oxygen-bridged cyclopentadiene skeleton [<xref rid="B51" ref-type="bibr">51</xref>]. This compound has cytotoxic activities toward various cell lines, including A549, HCC-S102 and HepG2 cells with IC<sub>50</sub> values ranging from 1.05 to 1.95 mg/ml. Recently, Xie et al. [<xref rid="B52" ref-type="bibr">52</xref>] have reported that DA-MED treatment drives Rac1 activation and promotes robust production of ROS, activating mitochondrial permeability transition and the intrinsic apoptotic pathway. Knockdown of Rac1 decreases ROS production in DA-MED-treated cells, resulting in a concomitant decrease in DA-MED-induced apoptosis. DA-MED-activated Rac1 induces autophagy by inhibiting mammalian target of rapamycin, leading to anti-apoptotic and anti-metastatic effects. Therefore, the present study provides novel insight into the complex cytotoxic and pro-survival mechanisms associated with a potent Rac1 agonist and suggests that further development of more potent Rac1 agonists could be an effective strategy for future non-small cell lung cancer treatments.</p><p><italic>Diallyl disulfide</italic> (DADS), one of the sulfur compounds derived from garlic, exhibits biological activity via modulating molecules and signaling pathways in various cell physiologies [<xref rid="B53" ref-type="bibr">53&#x02013;57</xref>]. These properties suggesting that DADS could be used as a potential therapeutic compound for the treatment or prevention of various diseases. Moreover, study has demonstrated that transforming growth factor-&#x003b2;1 (TGF-&#x003b2;1) could promote epithelial&#x02013;mesenchymal transition (EMT), invasion and proliferation through the activation of Rac1 and &#x003b2;-catenin signaling pathways. Therefore, Su et al. [<xref rid="B55" ref-type="bibr">55</xref>] have conducted a study for investigating the effects of DADS on TGF-&#x003b2;1-induced EMT and cellular invasion. Primarily, they found TGF-&#x003b2;1 treatment augmented EMT and invasion, concomitantly with increased expression of Rac1 and &#x003b2;-catenin. However, the DADS treatment could decrease the activities of Rac1 and &#x003b2;-catenin. DADS, TGF-&#x003b2;1 receptor inhibitor as well as Rac1 inhibitor antagonized the up-regulation of the TGF-&#x003b2;1-induced expression of these genes, abolishing the enhanced effects of TGF-&#x003b2;1 on EMT and invasion. These data indicated that the blockage of TGF-&#x003b2;1/Rac1 signaling by DADS may be responsible for the suppression of EMT and cellular invasion.</p><p>Mulberry (<italic>Morus alba L.</italic>) is a common fruit in temperate, subtropical and tropical areas, and contains abundant polyphenols and anthocyanin components [<xref rid="B58" ref-type="bibr">58</xref>,<xref rid="B59" ref-type="bibr">59</xref>]. Study showed the anthocyanins from the mulberry could inhibit the B16-F1 cell linage invasion [<xref rid="B60" ref-type="bibr">60</xref>]. The underlying molecular mechanisms is anthocyanins partly suppressed the Ras/PI3K signaling pathway. In addition, mulberry polyphenol extract (MPE) is rich in polyphenols that have antioxidant, anti-inflammatory, anti-aging, anti-obesity and anti-tumor effects. Considering the biological effects of anthocyanins, further study performed by Yu et al. [<xref rid="B58" ref-type="bibr">58</xref>] investigated that MPE on treating vascular smooth muscle cellular migration and proliferation. Their results showed that MPE could suppress the expression of FAK, Src, PI3K, Akt, c-Raf, and inhibit the signaling axis of FAK/Src/PI3K in cell. Besides that, their study also showed that MPE decrease the expression of small Rac1 and Cdc42 to affect F-actin cytoskeleton rearrangement.</p><p>As aforementioned, cytoskeletal structure rearrangement grant various cellular functions in various cell linages, such as: podosome patterning in osteoclasts and EMT transition. This has led to a surge in the efforts for identification of safer and more effective compounds which can modulate these cellular behaviors. <italic>Plectranthoic acid</italic> (PA), a natural compound isolated from the extracts of <italic>Ficus microcarpa</italic>, has been reported to possess the capability to induce cell cycle arrest and apoptosis in prostate cancer cells [<xref rid="B61" ref-type="bibr">61</xref>,<xref rid="B62" ref-type="bibr">62</xref>]. Recently, Akhtar et al. [<xref rid="B61" ref-type="bibr">61</xref>] extensively studied the PA biological effects on suppressing the cellular migration. Through the proteomic analysis, authors identified that Rac1 is the major cadherin signaling protein modulated with PA treatment.</p></sec><sec id="sec1-6"><title>Cdc42 regulative natural products</title><p><italic>Cudrania cochinchinensis</italic> (Moraceae) has been reported for its potent biological activites such as: anti-inflammation [<xref rid="B63" ref-type="bibr">63</xref>] and neuroprotective effects [<xref rid="B64" ref-type="bibr">64</xref>]. Whereas, the compound <italic>Cudraxanthone-S</italic> derived from <italic>C. cochinchinensis</italic> was studied for its pharmacokinetics and binding potential in treating the fungal infection of <italic>Candida albicans</italic>, which could cause several lethal infections in immune-suppressed patients and recently emerged as drug-resistant pathogens worldwide [<xref rid="B65" ref-type="bibr">65</xref>]. Authors found that <italic>Cudraxanthone-S</italic> had exhibited ability on regulating the Cdc42 in MAPK signaling pathway.</p><p><italic>Panacis Japonici Rhizoma</italic> (PJR), derived from dry rhizome of <italic>Panax japonicus C. A. Meyer</italic> (Araliaceae), distributes in the southwest of China [<xref rid="B66" ref-type="bibr">66&#x02013;68</xref>]. As a widely used focal medicine, the PJR manifested similar clinical merits in anti-tussive and anti-inflammatory diseases [<xref rid="B69" ref-type="bibr">69</xref>,<xref rid="B70" ref-type="bibr">70</xref>]. Recently, Chen et al. [<xref rid="B71" ref-type="bibr">71</xref>] have demonstrated that PJR could suppress the HEY and A2780 cells migration and invasion by decreasing the Cdc42 and Rac activities.</p><p><italic>Triptolide</italic> (TP), derived from the medicinal plant <italic>Triterygium wilfordii Hook. f.</italic> (TWHF), is a diterpene triepoxide with variety of biological and pharmacological activities [<xref rid="B72" ref-type="bibr">72</xref>]. Wang et al. [<xref rid="B73" ref-type="bibr">73</xref>] has studied the cytoskeletal structuring effects of TP on Sertoli cells, which play a critical role during spermatogenesis. Their study results demonstrate that TP can regulating the Sertoli cellular cytoskeleton structuring via inhibiting the expression of Cdc42.</p><p>The compound (<italic>4,5,4&#x02032;-trihydroxy-3,3&#x02032;-dimethoxybibenzyl</italic> (TDB)) extract from <italic>Dendrobium ellipsophyllum Tang and Wang</italic>, has been demonstrated to have antimetastatic activity through the sensitization of detachment-induced cell death [<xref rid="B74" ref-type="bibr">74</xref>,<xref rid="B75" ref-type="bibr">75</xref>]. Study from Chaotham et al. [<xref rid="B76" ref-type="bibr">76</xref>] showing that TDB reduced such cell migration and invasion by decreasing migration-regulating proteins, including integrins &#x003b1;v, &#x003b1;4, &#x003b2;1, &#x003b2;3 and &#x003b2;5, as well as downstream signaling proteins, such as activated focal adhesion kinase (pFAK), activated Rac1 and Cdc42. As the presence of cellular protrusion, called filopodia, has been indicated as a hallmark of migrating cells, we showed that the reduction in the mentioned proteins correlated well with the disappearance of filopodia. In summary, the present study demonstrates the promising activity of TDB and its mechanism in the inhibition of lung cancer cell migration, which might be useful for encouraging the development of this compound for anti-metastatic approaches.</p><p>Inhibition of VEGFR2 activity has been proposed as an important strategy for the clinical treatment of hepatocellular carcinoma (HCC). <italic>Corosolic acid</italic> (CA), which exists in the root of <italic>Actinidia chinensis</italic>, as having a significant anti-cancer effect on HCC cells by decreasing the tumor cellular migration. Ku et al. [<xref rid="B77" ref-type="bibr">77</xref>] have extensively studied the effects of CA on its cellular regulating effects found that CA inhibits VEGFR2 kinase activity by directly interacting with the ATP-binding pocket. Moreover, they found CA could decrease the VEGFR2/Src/FAK/Cdc42 axis, subsequently decreasing F-actin formation and migratory activity <italic>in vitro</italic>.</p><p><italic>Gigantol</italic> is a bibenzyl compound derived from the <italic>Thai orchid, Dendrobium draconis</italic>. It exhibits significant cytotoxic activity against several cancer cell lines. Study conducted by Charoenrungruang et al. [<xref rid="B78" ref-type="bibr">78</xref>] demonstrates that gigantol suppresses the migratory cellular behavior via decreasing Cdc42, thereby suppressing filopodia formation. The inhibitory activity of <italic>Gigantol</italic> on lung cancer cellular migration suggests that this compound may be suitable for further development for the treatment of osteoclastogenesis by regulating the osteoclastic cytoskeletal structuring.</p></sec></sec><sec sec-type="conclusion" id="sec2"><title>Conclusion</title><p>Characterized by the unique property, osteoclasts have been extensively studied for their differentiation and cellular functions during the bone homeostasis and pathological process, which makes them as a critical target for therapy in the bone loss diseases, such as: osteoporosis and osteolysis. Given that the low production costs and the increasing evidence of the ability to target the cellular activities and signaling cascades relevant to various diseases, naturally occurring compounds have received extensive attention as potential therapeutic osteoclastogenesis. Our current review has outlined some naturally occurring compounds, which have shown merit in terms of regulating macrophage polarization. However, given that current natural compounds have the Rac and Cdc42 regulatory effects on cancer cell line, the specific mechanisms and therapeutic effects on osteoclastognesis remain incompletely understood. Clearly, more in-depth characterization of osteoclast cytoskeleton rearrangement and relevant therapeutic compounds should be conducted to identify the best possible strategies.</p></sec></body><back><sec sec-type="data-availability" id="sec3"><title>Data Availability</title><p>All data and materials are included in the manuscript.</p></sec><sec id="sec4" sec-type="COI-statement"><title>Competing Interests</title><p>The authors declare that there are no competing interests associated with the manuscript.</p></sec><sec id="sec5" sec-type="funding"><title>Funding</title><p>This work was supported by the China Postdoctoral Science Foundation, P.R. China [grant number 2018T111085]; the Shaanxi Provincial Science and Technology Department, Science and Technology Achievement Transfer and Promotion Plan Award Achievement Transformation Project, P.R. China [grant number 2018HJCG-08]; the Xi&#x02019;an Science and Technology Bureau, Social Development Public Project [grant number 2017115 SF/YX009].</p></sec><sec id="sec6" sec-type="author-contrib"><title>Author Contribution</title><p>Yuan Liu, Yusheng Dou, Baorong He, Lingbo Kong: conception and design, drawing and interpretation of data; drafted the manuscript and revised it critically for important intellectual content; final approval of the version to be published. Liang Yan, Xiaobin Yang: acquisition of data (manuscript reviewing), analysis and interpretation of data. Wanli Smith: design, revision of the manuscript critically for important intellectual content. All authors had gave the final approval of the version to be published.</p></sec><sec id="sec7"><title>Consent for Publication</title><p>The manuscript is approved by all authors for publication.</p></sec><glossary><title>Abbreviations</title><def-list list-content="abbreviations"><def-item><term id="G1">Arp2/3</term><def><p>actin-related proteins-2/3</p></def></def-item><def-item><term id="G2">CA</term><def><p>corosolic acid</p></def></def-item><def-item><term id="G3">DADS</term><def><p>diallyl disulfide</p></def></def-item><def-item><term id="G4">DA-MED</term><def><p>deacetyl-mycoepoxydiene</p></def></def-item><def-item><term id="G5">DC</term><def><p>dendritic cell</p></def></def-item><def-item><term id="G6">EMT</term><def><p>epithelial&#x02013;mesenchymal transition</p></def></def-item><def-item><term id="G7">HCC</term><def><p>hepatocellular carcinoma</p></def></def-item><def-item><term id="G8">MPE</term><def><p>mulberry polyphenol extract</p></def></def-item><def-item><term id="G9">M-CSF</term><def><p>macrophage colony stimulating factor-1</p></def></def-item><def-item><term id="G10">PA</term><def><p>plectranthoic acid</p></def></def-item><def-item><term id="G11">PJR</term><def><p><italic>Panacis Japonici Rhizoma</italic></p></def></def-item><def-item><term id="G12">PKC</term><def><p>protein kinase C</p></def></def-item><def-item><term id="G13">RANKL</term><def><p>receptor activator of nuclear factor-&#x003ba;B ligand</p></def></def-item><def-item><term id="G14">ROS</term><def><p>reactive oxygen species</p></def></def-item><def-item><term id="G15">SZ</term><def><p>sealing zone</p></def></def-item><def-item><term id="G16">SZL</term><def><p>sealing zone like structure</p></def></def-item><def-item><term id="G17">TDB</term><def><p>4,5,4&#x02032;-trihydroxy-3,3&#x02032;-dimethoxybibenzyl</p></def></def-item><def-item><term id="G18">TGF-&#x003b2;1</term><def><p>transforming growth factor-&#x003b2;1</p></def></def-item><def-item><term id="G19">TP</term><def><p>triptolide</p></def></def-item><def-item><term id="G20">VEGFR</term><def><p>vascular endothelial growth factor receptor</p></def></def-item><def-item><term id="G21">WASp</term><def><p>Wiscott&#x02013;Aldrich Syndrome protein</p></def></def-item></def-list></glossary><ref-list id="ref1"><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feng</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Ye</surname><given-names>Q.</given-names></name> and <name name-style="western"><surname>Wu</surname><given-names>W.</given-names></name></person-group> (<year>2014</year>) <article-title>Osteoclastogenesis and osteoimmunology</article-title>. <source>Front. Biosci. (Landmark Ed.)</source>
<volume>19</volume>, <fpage>758</fpage>&#x02013;<lpage>767</lpage>
<pub-id pub-id-type="doi">10.2741/4242</pub-id><?supplied-pmid 24389219?><pub-id pub-id-type="pmid">24389219</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kukita</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kukita</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Watanabe</surname><given-names>T.</given-names></name> and <name name-style="western"><surname>Iijima</surname><given-names>T.</given-names></name></person-group> (<year>2001</year>) <article-title>Osteoclast differentiation antigen, distinct from receptor activator of nuclear factor kappa B, is involved in osteoclastogenesis under calcitonin-regulated conditions</article-title>. <source>J. Endocrinol.</source>
<volume>170</volume>, <fpage>175</fpage>&#x02013;<lpage>183</lpage>
<pub-id pub-id-type="doi">10.1677/joe.0.1700175</pub-id><?supplied-pmid 11431150?><pub-id pub-id-type="pmid">11431150</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baud&#x02019;huin</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Lamoureux</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Duplomb</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Redini</surname><given-names>F.</given-names></name> and <name name-style="western"><surname>Heymann</surname><given-names>D.</given-names></name></person-group> (<year>2007</year>) <article-title>RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases</article-title>. <source>Cell. Mol. Life Sci.</source>
<volume>64</volume>, <fpage>2334</fpage>&#x02013;<lpage>2350</lpage>
<pub-id pub-id-type="doi">10.1007/s00018-007-7104-0</pub-id><?supplied-pmid 17530461?><pub-id pub-id-type="pmid">17530461</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crotti</surname><given-names>T.N.</given-names></name>, <name name-style="western"><surname>Dharmapatni</surname><given-names>A.A.</given-names></name>, <name name-style="western"><surname>Alias</surname><given-names>E.</given-names></name> and <name name-style="western"><surname>Haynes</surname><given-names>D.R.</given-names></name></person-group> (<year>2015</year>) <article-title>Osteoimmunology: major and costimulatory pathway expression associated with chronic inflammatory induced bone loss</article-title>. <source>J. Immunol. Res.</source>
<volume>2015</volume>, <fpage>281287</fpage>
<pub-id pub-id-type="doi">10.1155/2015/281287</pub-id><?supplied-pmid 26064999?><pub-id pub-id-type="pmid">26064999</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Furlan</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Galbiati</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Jorgensen</surname><given-names>N.R.</given-names></name>, <name name-style="western"><surname>Jensen</surname><given-names>J.E.</given-names></name>, <name name-style="western"><surname>Mrak</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Rubinacci</surname><given-names>A.</given-names></name><etal>et al</etal>.</person-group> (<year>2007</year>) <article-title>Urokinase plasminogen activator receptor affects bone homeostasis by regulating osteoblast and osteoclast function</article-title>. <source>J. Bone Miner. Res.</source>
<volume>22</volume>, <fpage>1387</fpage>&#x02013;<lpage>1396</lpage>
<pub-id pub-id-type="doi">10.1359/jbmr.070516</pub-id><?supplied-pmid 17539736?><pub-id pub-id-type="pmid">17539736</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roscher</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Hasegawa</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Dohnke</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ocana-Morgner</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Amizuka</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Jessberger</surname><given-names>R.</given-names></name><etal>et al</etal>.</person-group> (<year>2016</year>) <article-title>The F-actin modulator SWAP-70 controls podosome patterning in osteoclasts</article-title>. <source>Bone Rep.</source>
<volume>5</volume>, <fpage>214</fpage>&#x02013;<lpage>221</lpage>
<pub-id pub-id-type="doi">10.1016/j.bonr.2016.07.002</pub-id><?supplied-pmid 28580389?><pub-id pub-id-type="pmid">28580389</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Georgess</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Machuca-Gayet</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Blangy</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Jurdic</surname><given-names>P.</given-names></name></person-group> (<year>2014</year>) <article-title>Podosome organization drives osteoclast-mediated bone resorption</article-title>. <source>Cell Adh. Migr.</source>
<volume>8</volume>, <fpage>191</fpage>&#x02013;<lpage>204</lpage>
<pub-id pub-id-type="doi">10.4161/cam.27840</pub-id><?supplied-pmid 24714644?><pub-id pub-id-type="pmid">24714644</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Planus</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Georgess</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Place</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Albiges-Rizo</surname><given-names>C.</given-names></name><etal>et al</etal>.</person-group> (<year>2011</year>) <article-title>Podosome rings generate forces that drive saltatory osteoclast migration</article-title>. <source>Mol. Biol. Cell</source>
<volume>22</volume>, <fpage>3120</fpage>&#x02013;<lpage>3126</lpage>
<pub-id pub-id-type="doi">10.1091/mbc.e11-01-0086</pub-id><?supplied-pmid 21737683?><pub-id pub-id-type="pmid">21737683</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luxenburg</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Addadi</surname><given-names>L.</given-names></name> and <name name-style="western"><surname>Geiger</surname><given-names>B.</given-names></name></person-group> (<year>2006</year>) <article-title>The molecular dynamics of osteoclast adhesions</article-title>. <source>Eur. J. Cell Biol.</source>
<volume>85</volume>, <fpage>203</fpage>&#x02013;<lpage>211</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejcb.2005.11.002</pub-id><?supplied-pmid 16360241?><pub-id pub-id-type="pmid">16360241</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jurdic</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Saltel</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Chabadel</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Destaing</surname><given-names>O.</given-names></name></person-group> (<year>2006</year>) <article-title>Podosome and sealing zone: specificity of the osteoclast model</article-title>. <source>Eur. J. Cell Biol.</source>
<volume>85</volume>, <fpage>195</fpage>&#x02013;<lpage>202</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejcb.2005.09.008</pub-id><?supplied-pmid 16546562?><pub-id pub-id-type="pmid">16546562</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Croke</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ross</surname><given-names>F.P.</given-names></name>, <name name-style="western"><surname>Korhonen</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>D.A.</given-names></name>, <name name-style="western"><surname>Zou</surname><given-names>W.</given-names></name> and <name name-style="western"><surname>Teitelbaum</surname><given-names>S.L.</given-names></name></person-group> (<year>2011</year>) <article-title>Rac deletion in osteoclasts causes severe osteopetrosis</article-title>. <source>J. Cell Sci.</source>
<volume>124</volume>, <fpage>3811</fpage>&#x02013;<lpage>3821</lpage>
<pub-id pub-id-type="doi">10.1242/jcs.086280</pub-id><?supplied-pmid 22114304?><pub-id pub-id-type="pmid">22114304</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Razzouk</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Lieberherr</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Cournot</surname><given-names>G.</given-names></name></person-group> (<year>1999</year>) <article-title>Rac-GTPase, osteoclast cytoskeleton and bone resorption</article-title>. <source>Eur. J. Cell Biol.</source>
<volume>78</volume>, <fpage>249</fpage>&#x02013;<lpage>255</lpage>
<pub-id pub-id-type="doi">10.1016/S0171-9335(99)80058-2</pub-id><?supplied-pmid 10350213?><pub-id pub-id-type="pmid">10350213</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Darden</surname><given-names>A.G.</given-names></name>, <name name-style="western"><surname>Ries</surname><given-names>W.L.</given-names></name>, <name name-style="western"><surname>Wolf</surname><given-names>W.C.</given-names></name>, <name name-style="western"><surname>Rodriguiz</surname><given-names>R.M.</given-names></name> and <name name-style="western"><surname>Key</surname><given-names>L.L.</given-names><suffix>Jr</suffix></name></person-group> (<year>1996</year>) <article-title>Osteoclastic superoxide production and bone resorption: stimulation and inhibition by modulators of NADPH oxidase</article-title>. <source>J. Bone Miner. Res.</source>
<volume>11</volume>, <fpage>671</fpage>&#x02013;<lpage>675</lpage>
<pub-id pub-id-type="doi">10.1002/jbmr.5650110515</pub-id><?supplied-pmid 9157782?><pub-id pub-id-type="pmid">9157782</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goettsch</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Babelova</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Trummer</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Erben</surname><given-names>R.G.</given-names></name>, <name name-style="western"><surname>Rauner</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Rammelt</surname><given-names>S.</given-names></name><etal>et al</etal>.</person-group> (<year>2013</year>) <article-title>NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis</article-title>. <source>J. Clin. Invest.</source>
<volume>123</volume>, <fpage>4731</fpage>&#x02013;<lpage>4738</lpage>
<pub-id pub-id-type="doi">10.1172/JCI67603</pub-id><?supplied-pmid 24216508?><pub-id pub-id-type="pmid">24216508</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bokoch</surname><given-names>G.M.</given-names></name></person-group> (<year>2005</year>) <article-title>Regulation of innate immunity by Rho GTPases</article-title>. <source>Trends Cell Biol.</source>
<volume>15</volume>, <fpage>163</fpage>&#x02013;<lpage>171</lpage>
<pub-id pub-id-type="doi">10.1016/j.tcb.2005.01.002</pub-id><?supplied-pmid 15752980?><pub-id pub-id-type="pmid">15752980</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kwong</surname><given-names>C.H.</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>A.G.</given-names></name> and <name name-style="western"><surname>Leto</surname><given-names>T.L.</given-names></name></person-group> (<year>1995</year>) <article-title>Characterization of the effector-specifying domain of Rac involved in NADPH oxidase activation</article-title>. <source>J. Biol. Chem.</source>
<volume>270</volume>, <fpage>19868</fpage>&#x02013;<lpage>19872</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.270.34.19868</pub-id><?supplied-pmid 7649999?><pub-id pub-id-type="pmid">7649999</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lacy</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Mahmudi-Azer</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Bablitz</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Gilchrist</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Fitzharris</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>D.</given-names></name><etal>et al</etal>.</person-group> (<year>1999</year>) <article-title>Expression and translocation of Rac2 in eosinophils during superoxide generation</article-title>. <source>Immunology</source>
<volume>98</volume>, <fpage>244</fpage>&#x02013;<lpage>252</lpage>
<pub-id pub-id-type="doi">10.1046/j.1365-2567.1999.00873.x</pub-id><?supplied-pmid 10540223?><pub-id pub-id-type="pmid">10540223</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Carnevale</surname><given-names>K.A.</given-names></name> and <name name-style="western"><surname>Cathcart</surname><given-names>M.K.</given-names></name></person-group> (<year>2003</year>) <article-title>Human monocytes use Rac1, not Rac2, in the NADPH oxidase complex</article-title>. <source>J. Biol. Chem.</source>
<volume>278</volume>, <fpage>40788</fpage>&#x02013;<lpage>40792</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M302208200</pub-id><?supplied-pmid 12912997?><pub-id pub-id-type="pmid">12912997</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>N.K.</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>Y.G.</given-names></name>, <name name-style="western"><surname>Baik</surname><given-names>J.Y.</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>S.Y.</given-names></name>, <name name-style="western"><surname>Jeong</surname><given-names>D.W.</given-names></name>, <name name-style="western"><surname>Bae</surname><given-names>Y.S.</given-names></name><etal>et al</etal>.</person-group> (<year>2005</year>) <article-title>A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation</article-title>. <source>Blood</source>
<volume>106</volume>, <fpage>852</fpage>&#x02013;<lpage>859</lpage>
<pub-id pub-id-type="doi">10.1182/blood-2004-09-3662</pub-id><?supplied-pmid 15817678?><pub-id pub-id-type="pmid">15817678</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Lebowitz</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Thang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Grynpas</surname><given-names>M.D.</given-names></name> and <name name-style="western"><surname>Glogauer</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>) <article-title>Identifying the relative contributions of Rac1 and Rac2 to osteoclastogenesis</article-title>. <source>J. Bone Miner. Res.</source>
<volume>23</volume>, <fpage>260</fpage>&#x02013;<lpage>270</lpage>
<pub-id pub-id-type="doi">10.1359/jbmr.071013</pub-id><?supplied-pmid 17922611?><pub-id pub-id-type="pmid">17922611</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shin</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Kupferman</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Polleux</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Delany</surname><given-names>A.M.</given-names></name> and <name name-style="western"><surname>Lee</surname><given-names>S.K.</given-names></name></person-group> (<year>2020</year>) <article-title>Rac1 inhibition via Srgap2 restrains inflammatory osteoclastogenesis and limits the Clastokine, SLIT3</article-title>. <source>J. Bone Miner. Res.</source>
<volume>35</volume>, <fpage>789</fpage>&#x02013;<lpage>800</lpage><pub-id pub-id-type="pmid">31880824</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guimbal</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Morel</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Guerit</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Chardon</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Blangy</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Vives</surname><given-names>V.</given-names></name></person-group> (<year>2019</year>) <article-title>Dock5 is a new regulator of microtubule dynamic instability in osteoclasts</article-title>. <source>Biol. Cell</source>
<volume>111</volume>, <fpage>271</fpage>&#x02013;<lpage>283</lpage>
<pub-id pub-id-type="doi">10.1111/boc.201900014</pub-id><?supplied-pmid 31461543?><pub-id pub-id-type="pmid">31461543</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soares</surname><given-names>M.P.R.</given-names></name>, <name name-style="western"><surname>Silva</surname><given-names>D.P.</given-names></name>, <name name-style="western"><surname>Uehara</surname><given-names>I.A.</given-names></name>, <name name-style="western"><surname>Ramos</surname><given-names>E.S.</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Alabarse</surname><given-names>P.V.G.</given-names></name>, <name name-style="western"><surname>Fukada</surname><given-names>S.Y.</given-names></name><etal>et al</etal>.</person-group> (<year>2019</year>) <article-title>The use of apocynin inhibits osteoclastogenesis</article-title>. <source>Cell Biol. Int.</source>
<volume>43</volume>, <fpage>466</fpage>&#x02013;<lpage>475</lpage>
<pub-id pub-id-type="doi">10.1002/cbin.11110</pub-id><?supplied-pmid 30761659?><pub-id pub-id-type="pmid">30761659</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>K.</given-names></name><etal>et al</etal>.</person-group> (<year>2018</year>) <article-title>TSC1 regulates osteoclast podosome organization and bone resorption through mTORC1 and Rac1/Cdc42</article-title>. <source>Cell Death Differ.</source>
<volume>25</volume>, <fpage>1549</fpage>&#x02013;<lpage>1566</lpage>
<pub-id pub-id-type="doi">10.1038/s41418-017-0049-4</pub-id><?supplied-pmid 29358671?><pub-id pub-id-type="pmid">29358671</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name><etal>et al</etal>.</person-group> (<year>2020</year>) <article-title>Dracorhodin perchlorate inhibits osteoclastogenesis through repressing RANKL-stimulated NFATc1 activity</article-title>. <source>J. Cell. Mol. Med.</source>
<volume>24</volume>, <fpage>3303</fpage>&#x02013;<lpage>3313</lpage><pub-id pub-id-type="pmid">31965715</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tasca</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Astleford</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Lederman</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Jensen</surname><given-names>E.D.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>B.S.</given-names></name>, <name name-style="western"><surname>Gopalakrishnan</surname><given-names>R.</given-names></name><etal>et al</etal>.</person-group> (<year>2017</year>) <article-title>Regulation of osteoclast differentiation by Myosin X</article-title>. <source>Sci. Rep.</source>
<volume>7</volume>, <fpage>7603</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-07855-9</pub-id><?supplied-pmid 28790434?><pub-id pub-id-type="pmid">28790434</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Itzstein</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Coxon</surname><given-names>F.P.</given-names></name> and <name name-style="western"><surname>Rogers</surname><given-names>M.J.</given-names></name></person-group> (<year>2011</year>) <article-title>The regulation of osteoclast function and bone resorption by small GTPases</article-title>. <source>Small GTPases</source>
<volume>2</volume>, <fpage>117</fpage>&#x02013;<lpage>130</lpage>
<pub-id pub-id-type="doi">10.4161/sgtp.2.3.16453</pub-id><?supplied-pmid 21776413?><pub-id pub-id-type="pmid">21776413</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gerasimcik</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Westerberg</surname><given-names>L.S.</given-names></name> and <name name-style="western"><surname>Severinson</surname><given-names>E.</given-names></name></person-group> (<year>2018</year>) <article-title>Methods to study the role of Cdc42, Rac1, and Rac2 in B-cell cytoskeletal responses</article-title>. <source>Methods Mol. Biol.</source>
<volume>1821</volume>, <fpage>235</fpage>&#x02013;<lpage>246</lpage>
<pub-id pub-id-type="doi">10.1007/978-1-4939-8612-5_16</pub-id><?supplied-pmid 30062416?><pub-id pub-id-type="pmid">30062416</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kotelevets</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Walker</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Mamadou</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Lehy</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Jordan</surname><given-names>P.</given-names></name> and <name name-style="western"><surname>Chastre</surname><given-names>E.</given-names></name></person-group> (<year>2018</year>) <article-title>The Rac1 splice form Rac1b favors mouse colonic mucosa regeneration and contributes to intestinal cancer progression</article-title>. <source>Oncogene</source>
<volume>37</volume>, <fpage>6054</fpage>&#x02013;<lpage>6068</lpage>
<pub-id pub-id-type="doi">10.1038/s41388-018-0389-7</pub-id><?supplied-pmid 29985482?><pub-id pub-id-type="pmid">29985482</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Lee</surname><given-names>S.Y.</given-names></name></person-group> (<year>2015</year>) <article-title>The scaffold protein RACK1 mediates the RANKL-dependent activation of p38 MAPK in osteoclast precursors</article-title>. <source>Sci. Signal.</source>
<volume>8</volume>, <fpage>ra54</fpage>
<pub-id pub-id-type="doi">10.1126/scisignal.2005867</pub-id><?supplied-pmid 26038599?><pub-id pub-id-type="pmid">26038599</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><etal>et al</etal>.</person-group> (<year>2015</year>) <article-title>Cofilin phosphorylation is elevated after F-actin disassembly induced by Rac1 depletion</article-title>. <source>Biofactors</source>
<volume>41</volume>, <fpage>352</fpage>&#x02013;<lpage>359</lpage>
<pub-id pub-id-type="doi">10.1002/biof.1235</pub-id><?supplied-pmid 26496994?><pub-id pub-id-type="pmid">26496994</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Joshi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>A.R.</given-names></name>, <name name-style="western"><surname>Zulcic</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Bao</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Messer</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ideker</surname><given-names>T.</given-names></name><etal>et al</etal>.</person-group> (<year>2014</year>) <article-title>Rac2 controls tumor growth, metastasis and M1-M2 macrophage differentiation in vivo</article-title>. <source>PLoS ONE</source>
<volume>9</volume>, <fpage>e95893</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0095893</pub-id><?supplied-pmid 24770346?><pub-id pub-id-type="pmid">24770346</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmed</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Prigmore</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Govind</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Veryard</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Kozma</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Wientjes</surname><given-names>F.B.</given-names></name><etal>et al</etal>.</person-group> (<year>1998</year>) <article-title>Cryptic Rac-binding and p21(Cdc42Hs/Rac)-activated kinase phosphorylation sites of NADPH oxidase component p67(phox)</article-title>. <source>J. Biol. Chem.</source>
<volume>273</volume>, <fpage>15693</fpage>&#x02013;<lpage>15701</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.273.25.15693</pub-id><?supplied-pmid 9624165?><pub-id pub-id-type="pmid">9624165</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manser</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Chong</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>Z.S.</given-names></name>, <name name-style="western"><surname>Leung</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Michael</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>C.</given-names></name><etal>et al</etal>.</person-group> (<year>1995</year>) <article-title>Molecular cloning of a new member of the p21-Cdc42/Rac-activated kinase (PAK) family</article-title>. <source>J. Biol. Chem.</source>
<volume>270</volume>, <fpage>25070</fpage>&#x02013;<lpage>25078</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.270.42.25070</pub-id><?supplied-pmid 7559638?><pub-id pub-id-type="pmid">7559638</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meriane</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Mary</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Comunale</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Vignal</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Fort</surname><given-names>P.</given-names></name> and <name name-style="western"><surname>Gauthier-Rouviere</surname><given-names>C.</given-names></name></person-group> (<year>2000</year>) <article-title>Cdc42Hs and Rac1 GTPases induce the collapse of the vimentin intermediate filament network</article-title>. <source>J. Biol. Chem.</source>
<volume>275</volume>, <fpage>33046</fpage>&#x02013;<lpage>33052</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M001566200</pub-id><?supplied-pmid 10900195?><pub-id pub-id-type="pmid">10900195</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ito</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Teitelbaum</surname><given-names>S.L.</given-names></name>, <name name-style="western"><surname>Zou</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>J.F.</given-names></name>, <name name-style="western"><surname>Chappel</surname><given-names>J.</given-names></name><etal>et al</etal>.</person-group> (<year>2010</year>) <article-title>Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarization</article-title>. <source>J. Clin. Invest.</source>
<volume>120</volume>, <fpage>1981</fpage>&#x02013;<lpage>1993</lpage>
<pub-id pub-id-type="doi">10.1172/JCI39650</pub-id><?supplied-pmid 20501942?><pub-id pub-id-type="pmid">20501942</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>H.K.</given-names></name>, <name name-style="western"><surname>Shin</surname><given-names>J.H.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>K.H.</given-names></name>, <name name-style="western"><surname>Huh</surname><given-names>J.Y.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>S.A.</given-names></name><etal>et al</etal>.</person-group> (<year>2009</year>) <article-title>Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice</article-title>. <source>J. Clin. Invest.</source>
<volume>119</volume>, <fpage>813</fpage>&#x02013;<lpage>825</lpage>
<pub-id pub-id-type="doi">10.1172/JCI36809</pub-id><?supplied-pmid 19258703?><pub-id pub-id-type="pmid">19258703</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mediero</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Perez-Aso</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Cronstein</surname><given-names>B.N.</given-names></name></person-group> (<year>2014</year>) <article-title>Activation of EPAC1/2 is essential for osteoclast formation by modulating NFkappaB nuclear translocation and actin cytoskeleton rearrangements</article-title>. <source>FASEB J.</source>
<volume>28</volume>, <fpage>4901</fpage>&#x02013;<lpage>4913</lpage>
<pub-id pub-id-type="doi">10.1096/fj.14-255703</pub-id><?supplied-pmid 25122553?><pub-id pub-id-type="pmid">25122553</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Touaitahuata</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Blangy</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Vives</surname><given-names>V.</given-names></name></person-group> (<year>2014</year>) <article-title>Modulation of osteoclast differentiation and bone resorption by Rho GTPases</article-title>. <source>Small GTPases</source>
<volume>5</volume>, <fpage>e28119</fpage>
<pub-id pub-id-type="doi">10.4161/sgtp.28119</pub-id><?supplied-pmid 24614674?><pub-id pub-id-type="pmid">24614674</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amato</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Thomason</surname><given-names>P.A.</given-names></name>, <name name-style="western"><surname>Davidson</surname><given-names>A.J.</given-names></name>, <name name-style="western"><surname>Swaminathan</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ismail</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Machesky</surname><given-names>L.M.</given-names></name><etal>et al</etal>.</person-group> (<year>2019</year>) <article-title>WASP restricts active rac to maintain cells&#x02019; front-rear polarization</article-title>. <source>Curr. Biol.</source>
<volume>29</volume>, <fpage>4169.e4164</fpage>&#x02013;<lpage>4182.e4164</lpage>
<pub-id pub-id-type="doi">10.1016/j.cub.2019.10.036</pub-id><pub-id pub-id-type="pmid">31786060</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bonfim-Melo</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Ferreira</surname><given-names>E.R.</given-names></name> and <name name-style="western"><surname>Mortara</surname><given-names>R.A.</given-names></name></person-group> (<year>2018</year>) <article-title>Rac1/WAVE2 and Cdc42/N-WASP participation in actin-dependent host cell invasion by extracellular amastigotes of <italic>Trypanosoma cruzi</italic></article-title>. <source>Front. Microbiol.</source>
<volume>9</volume>, <fpage>360</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2018.00360</pub-id><?supplied-pmid 29541069?><pub-id pub-id-type="pmid">29541069</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tetley</surname><given-names>G.J.N.</given-names></name>, <name name-style="western"><surname>Szeto</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Fountain</surname><given-names>A.J.</given-names></name>, <name name-style="western"><surname>Mott</surname><given-names>H.R.</given-names></name> and <name name-style="western"><surname>Owen</surname><given-names>D.</given-names></name></person-group> (<year>2018</year>) <article-title>Bond swapping from a charge cloud allows flexible coordination of upstream signals through WASP: multiple regulatory roles for the WASP basic region</article-title>. <source>J. Biol. Chem.</source>
<volume>293</volume>, <fpage>15136</fpage>&#x02013;<lpage>15151</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.RA118.003290</pub-id><?supplied-pmid 30104412?><pub-id pub-id-type="pmid">30104412</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Menotti</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ambrogio</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Cheong</surname><given-names>T.C.</given-names></name>, <name name-style="western"><surname>Pighi</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Mota</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Cassel</surname><given-names>S.H.</given-names></name><etal>et al</etal>.</person-group> (<year>2019</year>) <article-title>Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma</article-title>. <source>Nat. Med.</source>
<volume>25</volume>, <fpage>130</fpage>&#x02013;<lpage>140</lpage>
<pub-id pub-id-type="doi">10.1038/s41591-018-0262-9</pub-id><?supplied-pmid 30510251?><pub-id pub-id-type="pmid">30510251</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carabeo</surname><given-names>R.A.</given-names></name>, <name name-style="western"><surname>Dooley</surname><given-names>C.A.</given-names></name>, <name name-style="western"><surname>Grieshaber</surname><given-names>S.S.</given-names></name> and <name name-style="western"><surname>Hackstadt</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>) <article-title>Rac interacts with Abi-1 and WAVE2 to promote an Arp2/3-dependent actin recruitment during chlamydial invasion</article-title>. <source>Cell. Microbiol.</source>
<volume>9</volume>, <fpage>2278</fpage>&#x02013;<lpage>2288</lpage>
<pub-id pub-id-type="doi">10.1111/j.1462-5822.2007.00958.x</pub-id><?supplied-pmid 17501982?><pub-id pub-id-type="pmid">17501982</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Egile</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Loisel</surname><given-names>T.P.</given-names></name>, <name name-style="western"><surname>Laurent</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Pantaloni</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Sansonetti</surname><given-names>P.J.</given-names></name><etal>et al</etal>.</person-group> (<year>1999</year>) <article-title>Activation of the CDC42 effector N-WASP by the Shigella flexneri IcsA protein promotes actin nucleation by Arp2/3 complex and bacterial actin-based motility</article-title>. <source>J. Cell Biol.</source>
<volume>146</volume>, <fpage>1319</fpage>&#x02013;<lpage>1332</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.146.6.1319</pub-id><?supplied-pmid 10491394?><pub-id pub-id-type="pmid">10491394</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Espinoza-Sanchez</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Metskas</surname><given-names>L.A.</given-names></name>, <name name-style="western"><surname>Chou</surname><given-names>S.Z.</given-names></name>, <name name-style="western"><surname>Rhoades</surname><given-names>E.</given-names></name> and <name name-style="western"><surname>Pollard</surname><given-names>T.D.</given-names></name></person-group> (<year>2018</year>) <article-title>Conformational changes in Arp2/3 complex induced by ATP, WASp-VCA, and actin filaments</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>115</volume>, <fpage>E8642</fpage>&#x02013;<lpage>E8651</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1717594115</pub-id><?supplied-pmid 30150414?><pub-id pub-id-type="pmid">30150414</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hytti</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Piippo</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Korhonen</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Honkakoski</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Kaarniranta</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Kauppinen</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>) <article-title>Fisetin and luteolin protect human retinal pigment epithelial cells from oxidative stress-induced cell death and regulate inflammation</article-title>. <source>Sci. Rep.</source>
<volume>5</volume>, <fpage>17645</fpage>
<pub-id pub-id-type="doi">10.1038/srep17645</pub-id><?supplied-pmid 26619957?><pub-id pub-id-type="pmid">26619957</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sinha</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Srivastava</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Joshi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Joshi</surname><given-names>U.J.</given-names></name> and <name name-style="western"><surname>Govil</surname><given-names>G.</given-names></name></person-group> (<year>2014</year>) <article-title>In-vitro anti-proliferative and anti-oxidant activity of galangin, fisetin and quercetin: role of localization and intermolecular interaction in model membrane</article-title>. <source>Eur. J. Med. Chem.</source>
<volume>79</volume>, <fpage>102</fpage>&#x02013;<lpage>109</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejmech.2014.04.002</pub-id><?supplied-pmid 24727463?><pub-id pub-id-type="pmid">24727463</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>A.K.</given-names></name>, <name name-style="western"><surname>Garg</surname><given-names>G.</given-names></name> and <name name-style="western"><surname>Rizvi</surname><given-names>S.I.</given-names></name></person-group> (<year>2018</year>) <article-title>Fisetin as a caloric restriction mimetic protects rat brain against aging induced oxidative stress, apoptosis and neurodegeneration</article-title>. <source>Life Sci.</source>
<volume>193</volume>, <fpage>171</fpage>&#x02013;<lpage>179</lpage>
<pub-id pub-id-type="doi">10.1016/j.lfs.2017.11.004</pub-id><?supplied-pmid 29122553?><pub-id pub-id-type="pmid">29122553</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jacob</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Thangarajan</surname><given-names>S.</given-names></name></person-group> (<year>2018</year>) <article-title>Fisetin impedes developmental methylmercury neurotoxicity via downregulating apoptotic signalling pathway and upregulating Rho GTPase signalling pathway in hippocampus of F1 generation rats</article-title>. <source>Int. J. Dev. Neurosci.</source>
<volume>69</volume>, <fpage>88</fpage>&#x02013;<lpage>96</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijdevneu.2018.07.002</pub-id><?supplied-pmid 30009881?><pub-id pub-id-type="pmid">30009881</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Du</surname><given-names>L.</given-names></name></person-group> (<year>2016</year>) <article-title>Optimization of genome shuffling for high-yield production of the antitumor deacetylmycoepoxydiene in an endophytic fungus of mangrove plants</article-title>. <source>Appl. Microbiol. Biotechnol.</source>
<volume>100</volume>, <fpage>7491</fpage>&#x02013;<lpage>7498</lpage>
<pub-id pub-id-type="doi">10.1007/s00253-016-7457-0</pub-id><?supplied-pmid 27067587?><pub-id pub-id-type="pmid">27067587</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Shen</surname><given-names>Y.</given-names></name></person-group> (<year>2018</year>) <article-title>Deacetylmycoepoxydiene is an agonist of Rac1, and simultaneously induces autophagy and apoptosis</article-title>. <source>Appl. Microbiol. Biotechnol.</source>
<volume>102</volume>, <fpage>5965</fpage>&#x02013;<lpage>5975</lpage>
<pub-id pub-id-type="doi">10.1007/s00253-018-9058-6</pub-id><?supplied-pmid 29740674?><pub-id pub-id-type="pmid">29740674</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Almatroodi</surname><given-names>S.A.</given-names></name>, <name name-style="western"><surname>Alsahli</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Almatroudi</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Rahmani</surname><given-names>A.H.</given-names></name></person-group> (<year>2019</year>) <article-title>Garlic and its active compounds: a potential candidate in the prevention of cancer by modulating various cell signalling pathways</article-title>. <source>Anticancer Agents Med. Chem.</source>
<volume>19</volume>, <fpage>1314</fpage>&#x02013;<lpage>1324</lpage>
<pub-id pub-id-type="doi">10.2174/1871520619666190409100955</pub-id><?supplied-pmid 30963982?><pub-id pub-id-type="pmid">30963982</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cobb-Abdullah</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lyles</surname><given-names>L.R.</given-names><suffix>II</suffix></name>, <name name-style="western"><surname>Odewumi</surname><given-names>C.O.</given-names></name>, <name name-style="western"><surname>Latinwo</surname><given-names>L.M.</given-names></name>, <name name-style="western"><surname>Badisa</surname><given-names>V.L.</given-names></name> and <name name-style="western"><surname>Abazinge</surname><given-names>M.</given-names></name></person-group> (<year>2019</year>) <article-title>Diallyl disulfide attenuation effect on transcriptome in rat liver cells against cadmium chloride toxicity</article-title>. <source>Environ. Toxicol.</source>
<volume>34</volume>, <fpage>950</fpage>&#x02013;<lpage>957</lpage>
<pub-id pub-id-type="doi">10.1002/tox.22766</pub-id><?supplied-pmid 31077537?><pub-id pub-id-type="pmid">31077537</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Su</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Zeng</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>T.</given-names></name><etal>et al</etal>.</person-group> (<year>2018</year>) <article-title>Diallyl disulfide inhibits TGFbeta1induced upregulation of Rac1 and betacatenin in epithelialmesenchymal transition and tumor growth of gastric cancer</article-title>. <source>Oncol. Rep.</source>
<volume>39</volume>, <fpage>2797</fpage>&#x02013;<lpage>2806</lpage>
<?supplied-pmid 29620286?><pub-id pub-id-type="pmid">29620286</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xia</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Su</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Oyang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>S.</given-names></name><etal>et al</etal>.</person-group> (<year>2019</year>) <article-title>Diallyl disulfide inhibits colon cancer metastasis by suppressing Rac1-mediated epithelial-mesenchymal transition</article-title>. <source>Onco Targets Ther.</source>
<volume>12</volume>, <fpage>5713</fpage>&#x02013;<lpage>5728</lpage>
<pub-id pub-id-type="doi">10.2147/OTT.S208738</pub-id><?supplied-pmid 31410018?><pub-id pub-id-type="pmid">31410018</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Su</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Liao</surname><given-names>Q.</given-names></name> and <name name-style="western"><surname>Su</surname><given-names>Q.</given-names></name></person-group> (<year>2013</year>) <article-title>DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion</article-title>. <source>Oncol. Rep.</source>
<volume>29</volume>, <fpage>605</fpage>&#x02013;<lpage>612</lpage>
<pub-id pub-id-type="doi">10.3892/or.2012.2168</pub-id><?supplied-pmid 23233092?><pub-id pub-id-type="pmid">23233092</pub-id></mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>M.H.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>T.Y.</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>H.H.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>H.P.</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>K.C.</given-names></name> and <name name-style="western"><surname>Wang</surname><given-names>C.J.</given-names></name></person-group> (<year>2018</year>) <article-title>Mulberry polyphenol extract inhibits FAK/Src/PI3K complex and related signaling to regulate the migration in A7r5 cells</article-title>. <source>J. Agric. Food Chem.</source>
<volume>66</volume>, <fpage>3860</fpage>&#x02013;<lpage>3869</lpage>
<pub-id pub-id-type="doi">10.1021/acs.jafc.8b00958</pub-id><?supplied-pmid 29606008?><pub-id pub-id-type="pmid">29606008</pub-id></mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Bi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Bilal</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kuang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Iqbal</surname><given-names>H.M.N.</given-names></name><etal>et al</etal>.</person-group> (<year>2019</year>) <article-title>Effects of dietary supplementation with mulberry (Morus alba L.) leaf polysaccharides on immune parameters of weanling pigs</article-title>. <source>Animals (Basel)</source>
<volume>10</volume>, <fpage>35</fpage></mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>H.P.</given-names></name>, <name name-style="western"><surname>Shih</surname><given-names>Y.W.</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>Y.C.</given-names></name>, <name name-style="western"><surname>Hung</surname><given-names>C.N.</given-names></name> and <name name-style="western"><surname>Wang</surname><given-names>C.J.</given-names></name></person-group> (<year>2008</year>) <article-title>Chemoinhibitory effect of mulberry anthocyanins on melanoma metastasis involved in the Ras/PI3K pathway</article-title>. <source>J. Agric. Food Chem.</source>
<volume>56</volume>, <fpage>9286</fpage>&#x02013;<lpage>9293</lpage>
<pub-id pub-id-type="doi">10.1021/jf8013102</pub-id><?supplied-pmid 18767864?><pub-id pub-id-type="pmid">18767864</pub-id></mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akhtar</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Syed</surname><given-names>D.N.</given-names></name>, <name name-style="western"><surname>Khan</surname><given-names>M.I.</given-names></name>, <name name-style="western"><surname>Adhami</surname><given-names>V.M.</given-names></name>, <name name-style="western"><surname>Mirza</surname><given-names>B.</given-names></name> and <name name-style="western"><surname>Mukhtar</surname><given-names>H.</given-names></name></person-group> (<year>2016</year>) <article-title>The pentacyclic triterpenoid, plectranthoic acid, a novel activator of AMPK induces apoptotic death in prostate cancer cells</article-title>. <source>Oncotarget</source>
<volume>7</volume>, <fpage>3819</fpage>&#x02013;<lpage>3831</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.6625</pub-id><?supplied-pmid 26683363?><pub-id pub-id-type="pmid">26683363</pub-id></mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Avila-Carrasco</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Majano</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Sanchez-Tomero</surname><given-names>J.A.</given-names></name>, <name name-style="western"><surname>Selgas</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Lopez-Cabrera</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Aguilera</surname><given-names>A.</given-names></name><etal>et al</etal>.</person-group> (<year>2019</year>) <article-title>Natural plants compounds as modulators of epithelial-to-mesenchymal transition</article-title>. <source>Front. Pharmacol.</source>
<volume>10</volume>, <fpage>715</fpage>
<pub-id pub-id-type="doi">10.3389/fphar.2019.00715</pub-id><?supplied-pmid 31417401?><pub-id pub-id-type="pmid">31417401</pub-id></mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bueno-Silva</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Alencar</surname><given-names>S.M.</given-names></name>, <name name-style="western"><surname>Koo</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Ikegaki</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Silva</surname><given-names>G.V.</given-names></name>, <name name-style="western"><surname>Napimoga</surname><given-names>M.H.</given-names></name><etal>et al</etal>.</person-group> (<year>2013</year>) <article-title>Anti-inflammatory and antimicrobial evaluation of neovestitol and vestitol isolated from Brazilian red propolis</article-title>. <source>J. Agric. Food Chem.</source>
<volume>61</volume>, <fpage>4546</fpage>&#x02013;<lpage>4550</lpage>
<pub-id pub-id-type="doi">10.1021/jf305468f</pub-id><?supplied-pmid 23607483?><pub-id pub-id-type="pmid">23607483</pub-id></mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hiep</surname><given-names>N.T.</given-names></name>, <name name-style="western"><surname>Kwon</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>D.W.</given-names></name>, <name name-style="western"><surname>Hwang</surname><given-names>B.Y.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>H.J.</given-names></name>, <name name-style="western"><surname>Mar</surname><given-names>W.</given-names></name><etal>et al</etal>.</person-group> (<year>2015</year>) <article-title>Isoflavones with neuroprotective activities from fruits of Cudrania tricuspidata</article-title>. <source>Phytochemistry</source>
<volume>111</volume>, <fpage>141</fpage>&#x02013;<lpage>148</lpage>
<pub-id pub-id-type="doi">10.1016/j.phytochem.2014.10.021</pub-id><?supplied-pmid 25487308?><pub-id pub-id-type="pmid">25487308</pub-id></mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gopal</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Muddebihalkar</surname><given-names>A.G.</given-names></name>, <name name-style="western"><surname>Skariyachan</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>C</surname><given-names>A.U.</given-names></name>, <name name-style="western"><surname>Kaveramma</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Praveen</surname><given-names>U.</given-names></name><etal>et al</etal>.</person-group> (<year>2019</year>) <article-title>Mitogen activated protein kinase-1 and cell division control protein-42 are putative targets for the binding of novel natural lead molecules: a therapeutic intervention against <italic>Candida albicans</italic></article-title>. <source>J. Biomol. Struct. Dyn.</source>
<volume>29</volume>, <fpage>1</fpage>&#x02013;<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1080/07391102.2019.1682053</pub-id><?supplied-pmid 31625462?><pub-id pub-id-type="pmid">31625462</pub-id></mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Wang</surname><given-names>K.</given-names></name></person-group> (<year>2014</year>) <article-title>Chain conformation and anti-tumor activity of derivatives of polysaccharide from Rhizoma Panacis Japonici</article-title>. <source>Carbohydr. Polym.</source>
<volume>105</volume>, <fpage>308</fpage>&#x02013;<lpage>316</lpage>
<pub-id pub-id-type="doi">10.1016/j.carbpol.2014.01.089</pub-id><?supplied-pmid 24708985?><pub-id pub-id-type="pmid">24708985</pub-id></mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>Z.</given-names></name> and <name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name></person-group> (<year>2009</year>) <article-title>Chemical structures of water-soluble polysaccharides from Rhizoma Panacis Japonici</article-title>. <source>Carbohydr. Res.</source>
<volume>344</volume>, <fpage>1136</fpage>&#x02013;<lpage>1140</lpage>
<pub-id pub-id-type="doi">10.1016/j.carres.2009.02.014</pub-id><?supplied-pmid 19410242?><pub-id pub-id-type="pmid">19410242</pub-id></mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qi</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>C.</given-names></name><etal>et al</etal>.</person-group> (<year>2013</year>) <article-title>Determination of chikusetsusaponin V and chikusetsusaponin IV in rat plasma by liquid chromatography-mass spectrometry and its application to a preliminary pharmacokinetic study</article-title>. <source>Biomed. Chromatogr.</source>
<volume>27</volume>, <fpage>1568</fpage>&#x02013;<lpage>1573</lpage>
<pub-id pub-id-type="doi">10.1002/bmc.2961</pub-id><?supplied-pmid 23832283?><pub-id pub-id-type="pmid">23832283</pub-id></mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iijima</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Watanabe</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Ishiuchi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Matsumoto</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Watanabe</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Makino</surname><given-names>T.</given-names></name></person-group> (<year>2018</year>) <article-title>Interactions between crude drug extracts used in Japanese traditional Kampo medicines and organic anion-transporting polypeptide 2B1</article-title>. <source>J. Ethnopharmacol.</source>
<volume>214</volume>, <fpage>153</fpage>&#x02013;<lpage>159</lpage>
<pub-id pub-id-type="doi">10.1016/j.jep.2017.12.016</pub-id><?supplied-pmid 29248449?><pub-id pub-id-type="pmid">29248449</pub-id></mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sasaki</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Komatsu</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Nagumo</surname><given-names>S.</given-names></name></person-group> (<year>2008</year>) <article-title>Rapid detection of Panax ginseng by loop-mediated isothermal amplification and its application to authentication of Ginseng</article-title>. <source>Biol. Pharm. Bull.</source>
<volume>31</volume>, <fpage>1806</fpage>&#x02013;<lpage>1808</lpage>
<pub-id pub-id-type="doi">10.1248/bpb.31.1806</pub-id><?supplied-pmid 18758082?><pub-id pub-id-type="pmid">18758082</pub-id></mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>Q.S.</given-names></name>, <name name-style="western"><surname>Meng</surname><given-names>F.C.</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>Z.H.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>L.G.</given-names></name><etal>et al</etal>.</person-group> (<year>2016</year>) <article-title>Chikusetsusaponin IVa methyl ester induces G1 cell cycle arrest, triggers apoptosis and inhibits migration and invasion in ovarian cancer cells</article-title>. <source>Phytomedicine</source>
<volume>23</volume>, <fpage>1555</fpage>&#x02013;<lpage>1565</lpage>
<pub-id pub-id-type="doi">10.1016/j.phymed.2016.09.002</pub-id><?supplied-pmid 27823619?><pub-id pub-id-type="pmid">27823619</pub-id></mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yuan</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>T.</given-names></name><etal>et al</etal>.</person-group> (<year>2019</year>) <article-title>Application and mechanisms of triptolide in the treatment of inflammatory diseases-a review</article-title>. <source>Front. Pharmacol.</source>
<volume>10</volume>, <fpage>1469</fpage>
<pub-id pub-id-type="doi">10.3389/fphar.2019.01469</pub-id><?supplied-pmid 31866868?><pub-id pub-id-type="pmid">31866868</pub-id></mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Lv</surname><given-names>Z.M.</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>W.Q.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L.Y.</given-names></name> and <name name-style="western"><surname>Yan</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>) <article-title>Triptolide disrupts the actin-based Sertoli-germ cells adherens junctions by inhibiting Rho GTPases expression</article-title>. <source>Toxicol. Appl. Pharmacol.</source>
<volume>310</volume>, <fpage>32</fpage>&#x02013;<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1016/j.taap.2016.08.017</pub-id><?supplied-pmid 27554044?><pub-id pub-id-type="pmid">27554044</pub-id></mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaotham</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Pongrakhananon</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Sritularak</surname><given-names>B.</given-names></name> and <name name-style="western"><surname>Chanvorachote</surname><given-names>P.</given-names></name></person-group> (<year>2014</year>) <article-title>A Bibenzyl from Dendrobium ellipsophyllum inhibits epithelial-to-mesenchymal transition and sensitizes lung cancer cells to anoikis</article-title>. <source>Anticancer Res.</source>
<volume>34</volume>, <fpage>1931</fpage>&#x02013;<lpage>1938</lpage>
<?supplied-pmid 24692728?><pub-id pub-id-type="pmid">24692728</pub-id></mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sritularak</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Duangrak</surname><given-names>N.</given-names></name> and <name name-style="western"><surname>Likhitwitayawuid</surname><given-names>K.</given-names></name></person-group> (<year>2011</year>) <article-title>A new bibenzyl from Dendrobium secundum</article-title>. <source>Z. Naturforsch C. J. Biosci.</source>
<volume>66</volume>, <fpage>205</fpage>&#x02013;<lpage>208</lpage>
<pub-id pub-id-type="doi">10.1515/znc-2011-5-602</pub-id><?supplied-pmid 21812336?><pub-id pub-id-type="pmid">21812336</pub-id></mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaotham</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Chanvorachote</surname><given-names>P.</given-names></name></person-group> (<year>2015</year>) <article-title>A bibenzyl from Dendrobium ellipsophyllum inhibits migration in lung cancer cells</article-title>. <source>J. Nat. Med.</source>
<volume>69</volume>, <fpage>565</fpage>&#x02013;<lpage>574</lpage>
<pub-id pub-id-type="doi">10.1007/s11418-015-0925-5</pub-id><?supplied-pmid 26109451?><pub-id pub-id-type="pmid">26109451</pub-id></mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ku</surname><given-names>C.Y.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y.R.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>H.Y.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>S.C.</given-names></name> and <name name-style="western"><surname>Lin</surname><given-names>J.Y.</given-names></name></person-group> (<year>2015</year>) <article-title>Corosolic acid inhibits hepatocellular carcinoma cell migration by targeting the VEGFR2/Src/FAK pathway</article-title>. <source>PLoS ONE</source>
<volume>10</volume>, <fpage>e0126725</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0126725</pub-id><?supplied-pmid 25978354?><pub-id pub-id-type="pmid">25978354</pub-id></mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Charoenrungruang</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Chanvorachote</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Sritularak</surname><given-names>B.</given-names></name> and <name name-style="western"><surname>Pongrakhananon</surname><given-names>V.</given-names></name></person-group> (<year>2014</year>) <article-title>Gigantol, a bibenzyl from Dendrobium draconis, inhibits the migratory behavior of non-small cell lung cancer cells</article-title>. <source>J. Nat. Prod.</source>
<volume>77</volume>, <fpage>1359</fpage>&#x02013;<lpage>1366</lpage>
<pub-id pub-id-type="doi">10.1021/np500015v</pub-id><?supplied-pmid 24844664?><pub-id pub-id-type="pmid">24844664</pub-id></mixed-citation></ref></ref-list></back></article>